文献速递艾滋病与性传播感染

HIV-1感染后检测试剂的反应性出现时间及对结果解读的启示

Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.
PubMed 文献 · Clin Infect Dis · 2016-10-12

研究利用222份来自美国HIV-1血清阳转者的纵向血浆标本,评估Aptima HIV-1 RNA检测与20种FDA批准免疫检测之间的反应性间隔(ITRI),并结合模拟数据估算各检测的窗口期。结果显示ITRI随检测代次缩短(5.9-24.8天),窗口期概率分布的99百分位从44天(抗原抗体联合实验室筛查)到65天(Western blot)。这些可直接比较的估计有助于解读暴露后近期阴性结果及指导复检时机。

要点

  • 不同HIV检测的窗口期存在差异,抗原抗体联合检测约44天,Western blot约65天。
  • ITRI随检测代次更新而缩短,范围在5.9至24.8天之间。
  • 暴露后近期阴性结果需结合检测类型和窗口期解释,必要时复检。

核心结论

  • 20种HIV免疫检测的反应性出现时间可直接比较,窗口期99百分位从44天到65天不等。

研究设计与样本

  • 利用222份美国HIV-1血清阳转者的纵向血浆标本,采用区间删失生存和二项回归的多模型框架估算ITRI。

主要发现

  • ITRI随检测代次缩短,范围为5.9至24.8天。
  • 窗口期概率分布的99百分位:抗原抗体联合实验室筛查为44天,Western blot为65天。

临床怎么用

  • 可依据检测类型和窗口期向患者解释暴露后近期阴性结果,并指导复检时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the period of time between an exposure resulting in infection with human immunodeficiency virus (HIV) and when a test can reliably detect the presence of that infection, that is, the test window period, may benefit testing programs and clinicians in counseling patients about when the clinician and the patient can be confident a suspected exposure did not result in HIV infection. METHODS: We evaluated the intervals between reactivity of the Aptima HIV-1 RNA test (Aptima) and 20 US Food and Drug Administration-approved HIV immunoassays using 222 longitudinally collected plasma specimens from HIV-1 seroconverters from the United States. Using interval-censored survival and binomial regression approaches a multi-model framework was implemented to estimate the relative emergence of test reactivity, referred to here as an inter-test reactivity interval (ITRI). We then combined ITRI results with simulated data for the eclipse period, the time between exposure and detection of HIV virus by Aptima, to estimate the window period for each test. RESULTS: The estimated ITRIs were shorter with each new class of HIV tests, ranging from 5.9 to 24.8 days. The 99th percentiles of the window period probability distribution ranged from 44 days for laboratory screening tests that detect both antigen and antibody to 65 days for the Western blot test. CONCLUSIONS: Our directly comparable estimates of the emergence of reactivity for 20 immunoassays are valuable to testing providers for interpreting negative HIV test results obtained shortly after exposure, and for counseling individuals on when to retest after an exposure.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Delaney KP, Hanson DL, Masciotra S, et al. Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure. Clin Infect Dis. 2016. PMID: 27737954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。